Distribution of active glycogen synthase kinase 3β (GSK-3β) in brains staged for Alzheimer disease neurofibrillary changes

Journal of Neuropathology and Experimental Neurology

Volumn 58, Issue 9, 1999, Pages 1010-1019

  Pei, Jin Jing ^a   Braak, Eva ^b   Braak, Heiko ^b   Grundke Iqbal, Inge ^c   Iqbal, Khalid ^c   Winblad, Bengt ^a   Cowburn, Richard F ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b GOETHE UNIVERSITY   (Germany)

^c NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Alzheimer disease; Glycogen synthase kinase 3 ; Neurofibrillary changes

Indexed keywords

CASEIN KINASE; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; ENZYME LOCALIZATION; FEMALE; HUMAN; HUMAN TISSUE; MALE; NERVE CELL; NEUROFIBRILLARY TANGLE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION;

EID: 0032850599     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199909000-00011     Document Type: Article

References (55)

1. Braak H, Braak E. Neuropathological staging of Alzheimer related changes. Acta Neuropathol 1991;82:239-59
2. Braak H, Braak E, Grundke-Iqbal I, Iqbal K. Occurrence of neuropil threads in the senile human brain and in Alzheimer's disease: A third location of paired helical filaments outside of neurofibrillary tangles and neuritic plaques. Neurosci Lett 1986;65:351-55
3. Grundke-Iqbal I, Iqbal K, Quinlan M, Tung Y-C, Zaide MS, Wisniewski HM, Microtubule-associated protein tau: A component of Alzheimer paired helical filaments. J Biol Chem 1986;261:6084-89
4. Grundke-Iqbal I, Iqbal K, Tung Y-C, Quinlan M, Wisniewski HM, Binder I. Abnormal phosphorylation of the microtubule-associated protein tau in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 1986;83:4913-17
5. Iqbal K, Grundke-Iqbal I, Zaidi T, et al. Defective brain microtubule assembly in Alzheimer disease. Lancet 1986;2:421-26
6. Iqbal K, Grundke-Iqbal I, Smith AJ, George L, Tung Y-C, Zaidi T. Identification and localisation of a tau peptide to paired helical filaments of Alzheimer disease. Proc Natl Acad Sci USA 1989;86: 5646-50
7. Tomlinson BE, Blesses G, Roth M. Observations on the brains of demented old people. J Neurol Sci 1970;11:205-42
8. Alafuzoff I, Iqbal K, Friden H, Adolfsson R, Winblad B. Histopathological criteria for progressive dementia disorders: clinicalpathological correlation and classification by multivariate data analysis. Acta Neuropath 1987;74:209-25
9. Dickson DW, Crystal HA, Mattiace LA, et al. Identification of normal and pathological aging in prospectively studied non-demented elderly humans. Neurobiol Aging 1991;13:179-89
10. Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BY. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 1992;42:631-39
11. Almkvist O, Backman L. Progression in Alzheimer's disease: Sequencing of neuropsychological decline. Int J Geriatr Psychiatry 1993;8:755-63
12. Braak H, Duyckaerts C, Braak E, Piette F. Neuropathological staging of Alzheimer-related changes correlates with psychometrically assessed intellectual status. In: Corian B, Iqbal K, Nicolini M, Winblad B, Wisniewski H, Zatta P, eds. Alzheimer's disease: Advances in clinical and basic research. Third International Conference on Alzheimer's Disease and Related Disorders. Chichester: John Wiley & Sons, 1993:131-37
13. Geula C, Mesulam M-M, Saroff DM, Wu C-K. Relationship between plaques, tangles, and loss of cortical cholinergic fibers in Alzheimer disease. J Neuropathol Exp Neurol 1998;57:63-75
14. Ishiguro K, Takamatsu M, Tomizawa K, et al. Tau protein kinase I converts normal tau protein into A68 like component of paired helical filaments. J Biol Chem 1992;267:10897-901
15. Mandelkow E-M, Drewes G, Biernat J, et al. Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associate protein tau. FEBS Lett 1992;314:315-21
16. Drewes G, Lichtenberg-Kraag B, Doering F. Mitogen-activated protein (MAP) kinase transforms tau protein into an Alzheimer-like state. EMBO J 1992;6:2132-38
17. Ledesma MD, Correas I, Avila J, Diaz-Nido J. Implication of brain cdc2 and MAP2 kinases in the phosphorylation of tau protein in Alzheimer's disease. FEBS Lett 1992;308:218-24
18. Sengupta A, Wu Q, Grundke-Iqbal I, Iqbak K, Singh TJ. Potentiation of GSK-3-catalysed Alzheimer-like phosphorylation of human tau by cdk5. Mol Cell Biochem 1997;167:99-105
19. Pei J-J, Grundke-Iqbal I, Iqbal K, Bogdanovic N, Winblad B, Cowburn RF. Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimer's disease neurofibrillary degeneration. Brain Res 1998;797:267-77
20. Cohen P, Yellowlees D, Aitken A, Donella-Deana A, Hemmings BA, Parker PJ. Separation and characterization of glycogen synthase kinase-3, glycogen synthase kinase-4 and glycogen synthase kinase-5 from rabbit skeletal muscle. Eur J Biochem 1982;124:21-35
21. Cohen P, Alessi DR, Cross DAE. PDK1. One of the missing links in insulin signal transduction? FEBS Lett 1997;410:3-10
22. Stambolic V, Woodgett JR. Mitogen inactivation of glycogen synthase kinase-3 β in intact cells via serine 9 phosphorylation. Biochem J 1994;303:701-4
23. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings B. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 1995;378:785-89
24. Eldar-Finkelman H, Seger R, Vandenheede JR, Krebs EF. Inactivation of glycogen synthase kinase-3 by epidermal growth factor is mediated by mitogen-activated protein kinase/p90 ribosomal protein S6 kinase signaling pathway in NIH/3T3 cells. J Biol Chem 1995;270:987-90
25. Hughes K, Nikolakaki E, Plyte SE, Totty NF, Woodgett JR. Modulation of glycogen synthase kinase-3 family by tyrosine phosphorylation. EMBO J 1993;12:803-8
26. Cross DA, Alessi DR, Vandenheede JR, McDowell HE, Hundal HS, Cohen P. The inhibition of glycogen synthase kinase-3 by insulin or insulin-like growth factor 1 in the rat skeletal muscle cell line L6 is blocked by wortmannin, but not by rapamycin: Evidence that wortmannin blocks activation of the mitogen-activated protein kinase pathway in L6 cells between Ras and Raf. Biochem J 1994;303:21-26
27. Murai H, Okazaki M, Kikuchi A. Tyrosine dephosphorylation of glycogen kinase-3 is involved in its extracellular signal-dependent inactivation. FEBS Lett 1996;392:153-60
28. Ishiguro K, Shiratsuchi A, Sato S, et al. Glycogen synthase kinase 3β is identical to tau protein kinase I generating several epitopes of paired helical filaments. FEBS Lett 1993;325:167-72
29. Mulot SF, Hughes K, Woodgett JR, Anderton BH, Hanger DP. PHF-tau from Alzheimer's brain comprises four species on SDS-PAGE which can be mimicked by in vitro phosphorylation of human brain tau by glycogen synthase kinase-3 beta. FEBS Lett 1994;349:359-64
30. Imahori K, Uchida T. Physiology and pathology of tau protein kinases in relation to Alzheimer's Disease. J Biochem 1997;121:179-88
31. Hanger DP, Hughes K, Woodgett JR, Brion JP. Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: Generation of paired filament epitopes and neuronal localisation of the kinase. Neurosci Lett 1992;147:58-62
32. Yang S-D, Jau-Song Y, Shine-Gwo S, Jun-Jae H. Protein kinase Fa/ Glycogen synthase kinase-3α after heparin potentiation phosphorylates tau on sites abnormally phosphorylated in Alzheimer's disease brain. J Neurochem 1994;63:1416-25
33. Song J-S, Yang S-D. Tau protein kinase I/GSK-3 beta/kinase FA in heparin phosphorylates tau on Ser199, Thr231, Ser235, Ser262, Ser369, and Ser400 sites phosphorylated in Alzheimer disease brain. J Prot Chem 1995;14:95-105
34. Shiurba RA, Ishiguro K, Takashi M, et al. Immunocytochemistry of tau phosphoserine 413 and tau protein kinase I in Alzheimer pathology. Brain Res 1996;737:119-32
35. Singh TJ, Grundke-Iqbal I, Iqbal K. Differential phosphorylation of human tau isoforms containing three repeats by several protein kinase. Arch Biochem Biophys 1996;328:43-50
36. Lovestone S, Hugh-Reynolds C, Latimer D, et al. Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells. Current Biology 1994;4:1077-86
37. Sperber BR, Leight S, Goedert M, Lee VM-Y. Glycogen synthase kinase-3β phosphorylates tau protein at multiple sites in intact cells. Neurosci Lett 1995;197:149-53
38. Wagner U, Utton M, Gallo J-M, Miller CCJ. Cellular phosphorylation of tau by GSK-3β influences tau binding to microtubules and microtubule organization. J Cell Sci 1996;109:1537-43
39. Utton MA, Vandecandelaere A, Wagner U, et al. Phosphorylation of tau by glycogen synthase kinase 3-beta affects the ability of tau to promote microtubule self-assembly. Biochem J 1997;323:741-47
40. Hong M, Chen DCR, Klein PS, Lee VM-Y. Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3. J Biol Chem 1997;272:25332-62
41. Hong M, Lee VM-Y. Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons. J Biol Chem 1997;272:19547-53
42. Woodgett JR. Molecular cloning and expression of glycogen synthase kinase-3/Factor A. EMBO J 19990;9:2431-38
43. Takahashi M, Tomizawa K, Ishiguro K, Takamatsu M, Fujita SC, Imahori K. Involvement of τ protein kinase I in paired helical filament-like phosphorylation of the juvenile τ in rat brain. J Neurochem 1995;64:1759-68
44. Yamaguchi H, Ishiguro K, Uchida T, Takashima A, Lemere CA, Imahori K. Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPKI)/glycogen synthase kinase-3β and cyclin-dependent kinase 5, a component of TPK II. Acta Neuropathol 1996;92:232-41
45. Pei J-J, Tanaka T, Tung Y-C, Braak E, Iqbal K, Grundke-Iqbal I. Distribution, levels and activity of glycogen synthase kinase-3 in the Alzheimer disease brain. J Neuropath Exp Neurol 1997;6:70-78
46. Braak H, Braak E, Ohm T, Bohl J. Silver impregnation of Alzheimer's neurofibrillary changes counterstained for basophilic material and lipofuscin pigment. Stain Technol 1988;63:197-200
47. Gallyas F. Silver staining of Alzheimer's neurofibrillary changes by means of physical development. Acta Morphol Acad Sci Hung 1971;19:1-8
48. Braak E, Braak H, Mandelkow E-M. A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropath 1994;87:554-67
49. Campbell SK, Switzer RC, Martin TL. Alzheimer's plaques and tangles: A controlled and enhanced silver-staining method. Soc Neurosci Abstr 1987;13:678
50. Bancher C, Brunner C, Lassmann H, et al. Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease. Brain Res 1989;477:90-99
51. Wischik CM, Lai R, Edwards PC, et al. Quantitative analysis of tau protein in paired helical filament (PHF) preparations: Implications for the role of tau phosphorylation in PHF assembly in Alzheimer's disease. Neurobi Aging 1995;16:409-17
52. Gong C-X, Singh TJ, Grundke-Iqbal I, Iqbal K. Phosphoprotein phosphatase activities in Alzheimer disease. J Neurochem 1993;61: 921-27
53. Shaw M, Cohen P, Alessi DR. Further evidence that the inhibition of glycogen synthase kinase-3β by IGF-1 is mediated by PDK1/ PKB-induced phosphorylation of Ser-9 and not by dephosphorylation of Tyr-216. FEBS Lett 1997;416:307-11
54. Gong C-X, Shaikh S, Wang J-Z, Zaidi T, Grundke-Iqbal I, Iqbal K. Phosphatase activity toward abnormally phosphorylated τ: Decrease in Alzheimer disease brain. J Neurochem 1995;65:732-38
55. Kreutzberg GW. Microglia: A sensor for pathological events in the CNS. TINS 1996;19:312-18